Literature DB >> 21455775

Familial exudative vitreoretinopathy with an anterior segment vasoproliferative mass.

Maria Teresa Sandinha, Laura Crawley, Caroline Thaung, Lyndon Da Cruz.   

Abstract

Entities:  

Mesh：

Year:  2011        PMID： 21455775     DOI： 10.1007/s00417-011-1664-2

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN： 0721-832X            Impact factor:   3.117


× No keyword cloud information.
  7 in total

1.  The histopathology of familial exudative vitreoretinopathy. A report of two cases.

Authors:  E E Boldrey; P Egbert; J D Gass; T Friberg
Journal:  Arch Ophthalmol       Date:  1985-02

2.  Mutant frizzled-4 disrupts retinal angiogenesis in familial exudative vitreoretinopathy.

Authors:  Johane Robitaille; Marcia L E MacDonald; Ajamete Kaykas; Laird C Sheldahl; Jutta Zeisler; Marie-Pierre Dubé; Lin-Hua Zhang; Roshni R Singaraja; Duane L Guernsey; Binyou Zheng; Lee F Siebert; Ann Hoskin-Mott; Michael T Trese; Simon N Pimstone; Barkur S Shastry; Randall T Moon; Michael R Hayden; Y Paul Goldberg; Mark E Samuels
Journal:  Nat Genet       Date:  2002-08-12       Impact factor: 38.330

3.  Familial exudative vitreoretinopathy. Results of surgical management.

Authors:  S D Pendergast; M T Trese
Journal:  Ophthalmology       Date:  1998-06       Impact factor: 12.079

4.  A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy.

Authors:  Z Y Chen; E M Battinelli; A Fielder; S Bundey; K Sims; X O Breakefield; I W Craig
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

5.  Clinical and molecular evaluation of probands and family members with familial exudative vitreoretinopathy.

Authors:  F Nienke Boonstra; C Erik van Nouhuys; José Schuil; Ilse J de Wijs; Kim P van der Donk; Kostas Nikopoulos; Arijit Mukhopadhyay; Hans Scheffer; Mauk A D Tilanus; Frans P M Cremers; Lies H Hoefsloot
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-03-25       Impact factor: 4.799

6.  Treatment of vascularly active familial exudative vitreoretinopathy with pegaptanib sodium (Macugen).

Authors:  Polly A Quiram; Kimberly A Drenser; Michael M Lai; Antonio Capone; Michael T Trese
Journal:  Retina       Date:  2008-03       Impact factor: 4.256

7.  Mutations in LRP5 or FZD4 underlie the common familial exudative vitreoretinopathy locus on chromosome 11q.

Authors:  Carmel Toomes; Helen M Bottomley; Richard M Jackson; Katherine V Towns; Sheila Scott; David A Mackey; Jamie E Craig; Li Jiang; Zhenglin Yang; Richard Trembath; Geoffrey Woodruff; Cheryl Y Gregory-Evans; Kevin Gregory-Evans; Michael J Parker; Graeme C M Black; Louise M Downey; Kang Zhang; Chris F Inglehearn
Journal:  Am J Hum Genet       Date:  2004-03-11       Impact factor: 11.025
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.